Company Reports / Chongqing Holley Pharmaceutical Co. LTD

COMPANY: Chongqing Holley Pharmaceutical Co. LTD

INDEX RANK: 14th

Total Impact Score: 25,919.53

Chongqing Holley Pharmaceutical Co. LTD is ranked 14th place in our index for 2015. Chongqing Holley Pharmaceutical Co. LTD’s drugs have a total impact score of 25,919.53. Chongqing Holley Pharmaceutical Co. Ltd and Sigma Tau Industrie Farmaceutiche treats two diseases in our model - P. falc malaria and P. vivax malaria - with one total drug - DHA-Piperaquine (DHA-PPQ). Chongqing Holley Pharmaceutical Co. Ltd and Sigma Tau Industrie Farmaceutiche receives credit for one treatment against P. falc malaria - DHAPiperaquine (DHA-PPQ). This one drug averted 20,715.41 of the total DALYS for P. falc malaria, which is 0.09% of the worldwide DALYs that we estimate would have been lost due to P. falc malaria in 2015 in the absence of effective treatment. Chongqing Holley Pharmaceutical Co. Ltd and Sigma Tau Industrie Farmaceutiche’s drug portfolio placed it 3rd in terms of total averted DALYs for P. falc malaria. Chongqing Holley Pharmaceutical Co. Ltd and Sigma Tau Industrie Farmaceutiche receives credit for one treatment against P. vivax malaria - DHA-Piperaquine (DHA-PPQ). This one drug averted 5,204.12 of the total DALYS for P. vivax malaria, which is 1.33% of the worldwide DALYs that we estimate would have been lost due to P. vivax malaria in 2015 in the absence of effective treatment. Chongqing Holley Pharmaceutical Co. Ltd and Sigma Tau Industrie Farmaceutiche’s drug portfolio placed it 3rd in terms of total averted DALYs for P. vivax malaria.

Company Score Breakdown:

Key Drugs

DIHYDROARTEMISININ-PIPERAQUINE (DHA-P;DHA+PPQ)

Dihydroartemisinin-Piperaquine (DHA-P;DHA+PPQ) is an artemisinin combination therapy recommended by the WHO as one of the primary treatments for both uncomplicated and severe malaria. It is generally as safe and effective as AS+AQ, but provides a longer prophylactic effect due to its longer half-life. It was developed by Sigma-Tau in partnership with Medicines for Malaria Venture (MMV). In 2010, Chongqing Tonghe Pharmaceuticals Co. Ltd was awarded the patent.

Company Information

Holley Pharmaceuticals is an affiliate of the Chinese company Chongqing Holley with a manufacturing facility in California. Chongqing Holley advocates for corporate social responsibility to promote social well-being and help realize the value of life. Holley Pharmaceuticals, which established itself in the U.S. in 2002, is one of the world’s largest manufacturers of artemisinin, an antimalarial.

Company Report PDF

CONTACT US © 2017 GLOBAL HEALTH IMPACT